CEL SCI CORP (CVM)
About CEL SCI CORP
CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2014
- $264.0K
- Net income
- -$25.4M
- Total assets
- $28.2M
- Market cap
- $19.9M
- Operating margin
- 3823.1%
- Net margin
- -3915.7%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- -$648.9K
- Operating expenses
- $24.8M
- Operating income
- -$24.8M
- Net income
- $25.4M
- EPS (diluted)
- $-6.27
Balance sheet
- Total assets
- $28.2M
- Current assets
- $11.6M
- Total liabilities
- $12.2M
- Current liabilities
- $5.1M
- Shareholders’ equity
- $16.0M
Cash flow
- Operating cash flow
- -$17.1M
- Investing cash flow
- -$38.1K
- Financing cash flow
- $23.4M
- Net cash flow
- $6.2M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $19.9M
- EPS (diluted)
- $-6.27
- Shares outstanding
- 16.8M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Dec 8, 1983
CEL SCI Corp (CVM) Stock Price
- Reported a net loss of $25.4M in FY2014.
- Revenue grew 44% from FY2021 to FY2025.
- Trading 91% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review CEL SCI CORP.
Write a review
News about CEL SCI CORP
News & sentiment via Polygon.io
CEL SCI Corp: frequently asked questions
Is CEL SCI Corp an American company?
CEL SCI Corp is a US-based company headquartered in Vienna, Virginia, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is CEL SCI Corp headquartered?
CEL SCI Corp is headquartered in Vienna, Virginia, United States.
Is CEL SCI Corp publicly traded?
Yes — CEL SCI Corp is a publicly traded company. Its stock trades under the ticker symbol CVM on the NYSE.
What does CEL SCI Corp do?
CEL SCI Corp is an American Pharmaceuticals company in the Health & Beauty sector.
